Lacosamide Solution
Product Images NDC 69315-318

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 69315-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Containerlabel200ml (Containerlabel200ml)

Label for Lacosamide Oral Solution, USP 10 mg/mL, a prescription oral solution by Leading Pharma, LLC. The label includes dosage instructions, storage conditions, manufacturer details (Medley Pharmaceuticals Ltd, India), a barcode, and a container size of 200 mL. It features warnings for pharmacists and patients regarding medication dispensing and storage.*

FDA Label Image

Containerlabel465ml (Containerlabel465ml)

Lacosamide Oral Solution, USP 10 mg/mL in a 465 mL bottle by Leading Pharma, LLC. The label includes dosage strength, NDC 69315-318-46, storage instructions, and manufacturer details for Medley Pharmaceuticals Ltd, India. It also highlights pharmacist dispensing instructions and safety reminders.*

FDA Label Image

Lacosamide Fig 01 (Lacosamide Fig1)

Chemical structure of lacosamide, the active ingredient shown in the product data. The diagram displays the molecular arrangement including carbon, hydrogen, nitrogen, and oxygen atoms connected by various bonds.*

FDA Label Image

Lacosamide Fig 02 (Lacosamide Fig2)

A bar graph titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose.' It compares seizure reduction percentages for placebo and various doses of Lacosamide across three studies. The graph shows higher median seizure reductions with Lacosamide doses compared to placebo in all studies, with percentages ranging approximately from 10% to 40%.*

FDA Label Image

Lacosamide Fig 03 (Lacosamide Fig3)

A cumulative response rate graph showing the proportion of patients by responder rate for Lacosamide and placebo groups in clinical studies. The y-axis represents responder rate from worsening to improvement, and the x-axis shows the percent of patients. The chart compares placebo with Lacosamide at 200 mg/day, 400 mg/day, and 600 mg/day dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.